BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 30873178)

  • 21. Bridging Vaccine-Induced HIV-1 Neutralizing and Effector Antibody Responses in Rabbit and Rhesus Macaque Animal Models.
    Pollara J; Jones DI; Huffman T; Edwards RW; Dennis M; Li SH; Jha S; Goodman D; Kumar A; LaBranche CC; Montefiori DC; Fouda GG; Hope TJ; Tomaras GD; Staats HF; Ferrari G; Permar SR
    J Virol; 2019 May; 93(10):. PubMed ID: 30842326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-based reporter assays for measurements of antibody-mediated cellular cytotoxicity and phagocytosis against SARS-CoV-2 spike protein.
    Hong Y; Guo H; Wei M; Zhang Y; Fang M; Cheng T; Li Z; Ge S; Yao X; Yuan Q; Xia N
    J Virol Methods; 2022 Sep; 307():114564. PubMed ID: 35671888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.
    Leon PE; He W; Mullarkey CE; Bailey MJ; Miller MS; Krammer F; Palese P; Tan GS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(40):E5944-E5951. PubMed ID: 27647907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210.
    Watanabe M; Wallace PK; Keler T; Deo YM; Akewanlop C; Hayes DF
    Breast Cancer Res Treat; 1999 Feb; 53(3):199-207. PubMed ID: 10369066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cocrystal Structures of Antibody N60-i3 and Antibody JR4 in Complex with gp120 Define More Cluster A Epitopes Involved in Effective Antibody-Dependent Effector Function against HIV-1.
    Gohain N; Tolbert WD; Acharya P; Yu L; Liu T; Zhao P; Orlandi C; Visciano ML; Kamin-Lewis R; Sajadi MM; Martin L; Robinson JE; Kwong PD; DeVico AL; Ray K; Lewis GK; Pazgier M
    J Virol; 2015 Sep; 89(17):8840-54. PubMed ID: 26085162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus.
    He W; Tan GS; Mullarkey CE; Lee AJ; Lam MM; Krammer F; Henry C; Wilson PC; Ashkar AA; Palese P; Miller MS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11931-11936. PubMed ID: 27698132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of IgG Isotype on the Induction of Antibody-Dependent Cellular Phagocytosis of HIV by Human Milk Leukocytes.
    Fox A; Liu X; Zolla-Pazner S; Powell RL
    Front Immunol; 2022; 13():831767. PubMed ID: 35592337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a novel reporter gene assay to evaluate antibody-dependent cellular phagocytosis for anti-CD20 therapeutic antibodies.
    Liu C; Yu C; Yang Y; Huang J; Yu X; Duan M; Wang L; Wang J
    Int Immunopharmacol; 2021 Nov; 100():108112. PubMed ID: 34521023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of antibody and complement in the control of viral infections.
    Cooper NR; Nemerow GR
    J Invest Dermatol; 1984 Jul; 83(1 Suppl):121s-127s. PubMed ID: 6376646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel method for determining antibody-dependent cellular phagocytosis.
    Kamen L; Myneni S; Langsdorf C; Kho E; Ordonia B; Thakurta T; Zheng K; Song A; Chung S
    J Immunol Methods; 2019 May; 468():55-60. PubMed ID: 30880262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles.
    Brown EP; Dowell KG; Boesch AW; Normandin E; Mahan AE; Chu T; Barouch DH; Bailey-Kellogg C; Alter G; Ackerman ME
    J Immunol Methods; 2017 Apr; 443():33-44. PubMed ID: 28163018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Method for Measurement of Antibody-Dependent Cellular Phagocytosis.
    Kamen L; Ordonia B; Myneni S; Chung S
    Methods Mol Biol; 2022; 2313():305-312. PubMed ID: 34478147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of Fc-Mediated Effector Functions Against a Stabilized Inner Domain of HIV-1 gp120 Designed to Selectively Harbor the A32 Epitope Region.
    Visciano ML; Gohain N; Sherburn R; Orlandi C; Flinko R; Dashti A; Lewis GK; Tolbert WD; Pazgier M
    Front Immunol; 2019; 10():677. PubMed ID: 31001276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
    Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies.
    Gogesch P; Dudek S; van Zandbergen G; Waibler Z; Anzaghe M
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protocol for the murine antibody-dependent cellular phagocytosis assay.
    Stanganello E; Brkic M; Zenner S; Beulshausen I; Schmitt U; Vascotto F
    Methods Cell Biol; 2023; 173():109-120. PubMed ID: 36653078
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fc receptors in antibody-dependent enhancement of viral infections.
    Taylor A; Foo SS; Bruzzone R; Dinh LV; King NJ; Mahalingam S
    Immunol Rev; 2015 Nov; 268(1):340-64. PubMed ID: 26497532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced antibody-dependent cellular phagocytosis by chimeric monoclonal antibodies with tandemly repeated Fc domains.
    Nagashima H; Ootsubo M; Fukazawa M; Motoi S; Konakahara S; Masuho Y
    J Biosci Bioeng; 2011 Apr; 111(4):391-6. PubMed ID: 21215693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monoclonal Antibodies Specific for the V2, V3, CD4-Binding Site, and gp41 of HIV-1 Mediate Phagocytosis in a Dose-Dependent Manner.
    Musich T; Li L; Liu L; Zolla-Pazner S; Robert-Guroff M; Gorny MK
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody.
    Gehlert CL; Rahmati P; Boje AS; Winterberg D; Krohn S; Theocharis T; Cappuzzello E; Lux A; Nimmerjahn F; Ludwig RJ; Lustig M; Rösner T; Valerius T; Schewe DM; Kellner C; Klausz K; Peipp M
    Front Immunol; 2022; 13():957874. PubMed ID: 36119088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.